General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Bifidobacterium mongoliense is a Gram-positive, non-spore-forming, facultatively anaerobic, non-motile, rod-shaped bacterium. It has been detected in at least 2 gut microbiome compilation studies or metastudies. The DNA G+C content is 61.1-61.9%. Bifidobacterium mongoliense is likely to be transient and not a long-term gut coloniser. (Watanabe2009; Milani2019)



  • This organism has been recovered from human faeces, and fermented mare's milk. Pathogenicity status unknown, or very unlikely to be pathogenic. Likely to be transient and not a long-term gut commensal.

  • QUIRKS
  • Known to temporarily colonise the human gut through the ingestion of parmesan cheese. Unlikely long-term gut coloniser.

  • GENERAL CHARACTERISTICS (Watanabe2009);
    Character Response
  • Substrates hydrolysed or digested:
  • aesculin;
  • pH
  • Acidity tolerance:
  • tolerates pH 4.5; tolerates pH 8; Grows optimally at pH 6.5-7.0.
  • 🌡
  • Temperature tolerance:
  • grows at 15℃; grows at 37℃; doesn't grow at 41℃;
  • H+
  • Acid from carbohydrates usually produced:
  • L-arabinose; galactose; glucose; glycogen; lactose; maltose; melibiose; raffinose; sucrose; D-turanose; α-methyl glucoside;
  • Substrates assimilated or utilised:
  • melibiose;

  • SPECIAL FEATURES (Watanabe2009);
    Character Response
  • Metabolites produced:
  • acetate; lactate;
  • Metabolites not produced:
  • indole;

  • RESPONSE TO ANTIBIOTICS
    Class Active Resistant
  • Penicillins:
  • amoxicillin; amoxicillin-clavulanic acid; ampicillin; cloxacillin; imipenem; oxacillin; penicillin G; piperacillin; ticarcillin;
  • Cephalosporins:
  • cefotaxime; cefotetan; cefoxitin; cephalothin;
  • Macrolides:
  • erythromycin; pristinamycin; spiramycin; telithromycin;
  • Tetracyclines:
  • minocycline; tetracycline;
  • Quinolines:
  • ciprofloxacin; gatifloxacin;
  • nalidixic-acid;
  • Aminoglycosides:
  • gentamicin; kanamycin; neomycin;
  • Polypep/ketides:
  • rifampicin;
  • Heterocycles:
  • chloramphenicol;
  • Vancomycins:
  • vancomycin; teicoplanin;
  • Miscellaneous antibiotics:
  • lincomycin; pristinamycin; telithromycin;

  • Lagier, J.-C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., Bittar, F., Fournous, G., Gimenez, G., Maraninchi, M., Trape, J.-F., Koonin, E. V., La Scola, B., & Raoult, D. (2012). Microbial culturomics: paradigm shift in the human gut microbiome study. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 18(12), 1185–1193.


  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Actinobacteria Class:  Actinomycetia Order:  Bifidobacteriales Family:  Bifidobacteriaceae Genus:  Bifidobacterium Gram stain:  + O2 Relation.:  facultatively anaerobic Spore:  No spore Motility:  Sessile Morphology:  Rod
    Health:  Unknown
    Source:  human faeces, and fermented mare's milk
    DNA G+C(%):  61.1-61.9
    Low T(℃):  15(+)
    Mid T(℃):  37(+)
    High T(℃):  41(neg)
    Opt. pH:  6.5-7.0
    pH 4.2-5.9:  4.5(+)
    pH 6.0-8.0:  8(+)
    Aesculin:  + Gelatin:  neg

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    D-Arabinose:  neg L-Arabinose:  + Fructose:  neg Fucose:  neg D-Fucose:  neg Galactose:  + Glucose:  + Mannose:  neg D-Lyxose:  neg Rhamnose:  neg Ribose:  vr Sorbose:  neg D-Tagatose:  neg Xylose:  neg L-Xylose:  neg Cellubiose:  vr Gentiobiose:  vr Lactose:  + Maltose:  + Melezitose:  neg Melibiose:  + Sucrose:  + Trehalose:  neg Turanose:  + Amygdalin:  vr Glycogen:  + Inulin:  neg Starch:  w Adonitol:  neg D-Arabitol:  neg L-Arabitol:  neg Dulcitol:  neg Erythritol:  neg Glycerol:  neg Inositol:  neg Mannitol:  neg Sorbitol:  neg Xylitol:  neg Arbutin:  vr Gluconate:  vr 2-Ketogluconate:  neg 5-Ketogluconate:  neg Me-α-D-Glc:  + Me-α-D-Mann:  neg Me-Xyloside:  neg NAc-α-GA:  neg Salicin:  vr

    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Melibiose:  +

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  neg

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Acetate:  + Lactate:  + Indole:  neg

    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    amoxicillin:  Sens
    Augmentin:  Sens
    ampicillin:  Sens
    cloxacillin:  Sens
    oxacillin:  Sens
    penicillin_G:  Sens
    piperacillin:  Sens
    ticarcillin:  Sens
    imipenem:  Sens
    cefotaxime:  Sens
    cefotetan:  Sens
    cefoxitin:  Sens
    cephalothin:  Sens
    gentamicin:  Res
    kanamycin:  Res
    neomycin:  Res
    erythromycin:  Sens
    pristinamycin:  Sens
    spiramycin:  Sens
    telithromycin:  Sens
    ciprofloxacin:  Sens
    gatifloxacin:  Sens
    nalidixic-acid:  Res
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    minocycline:  S(vr)
    tetracycline:  S(vr)
    teicoplanin:  Sens
    vancomycin:  Sens
    rifampicin:  Sens
    chloramphenicol:  Sens
    metronidazole:  Var
    lincomycin:  Sens

    References


    SPECIFIC REFERENCES FOR BIFIDOBACTERIUM MONGOLIENSE
  • Watanabe2009 - Bifidobacterium mongoliense sp. nov., from airag, a traditional fermented mare's milk product from Mongolia.
  • Milani2019 - Colonization of the human gut by bovine bacteria present in Parmesan cheese.
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR BIFIDOBACTERIUM MONGOLIENSE
  • Byrd2020 - Stability and dynamics of the human gut microbiome and its association with systemic immune traits.
  • RajilicStojanovic2014 - The first 1000 cultured species of the human gastrointestinal microbiota.
  • ...............................